HER2/VEGFR targeting biological therapeutics (Beijing Hanmi Pharmaceutical)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHER2/VEGFR targeting biological therapeutics (Beijing Hanmi Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor modulatorsReceptor protein-tyrosine kinase erbB-2 modulators
TargetsVascular endothelial growth factorReceptor protein-tyrosine kinase erbB-2
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Hanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Hanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A